Trex Bio, Inc.: J.P. Morgan initiates coverage with overweight rating; price target $20
TRXB•J.P. Morgan initiated coverage of Trex Bio, Inc. with an overweight rating and a $20 price target.
Related News
Berkshire-owned utility's wildfire lawsuits head to Oregon Supreme Court
BRK.B•
JD.com meets all closing conditions for CECONOMY takeover
JD•
Valley National Bancorp target price raised to $17 from $15
VLY•
Barclays raises FIGS target price to $24 from $20
FIGS•
Rupee nudges higher, forward premiums dip as markets focus on US midterms and oil moves
INDA•